Investors

Corporate Profile

Echo Therapeutics, Inc. (NASDAQ: ECTE) is a transdermal medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Prelude^® SkinPrep System as a platform technology to allow for significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. Utilizing the patented, core skin permeation technology found in Prelude, Echo is developing its needle-free Symphony^® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in hospital critical care units and for people with diabetes.

Dr. Robert Langer Interview

Listen to the Chairman of Echo Therapeutic's Scientific Advisory Board, Dr. Robert Langer, discuss their Prelude^® SkinPrep device as well as their Symphony^® tCGM system with Life Tech Capital:
http://www.lifetechcapital.com/echo.htm